Drug-eluting stents/implants, balloon sinuplasty, and procedural device innovation.
6 tracked publications · last updated 2026-06-04
Related: AI & Machine Learning · Robotics, Automation & Ergonomics · Navigation, AR-VR, Simulation & 3D Printing · Biologics & Medical Therapy · Endotypes, Biomarkers & Diagnostics · Skull Base Surgery & Reconstruction · Outcomes, Guidelines & Epidemiology
Publications
-
Steroid-eluting stents in chronic rhinosinusitis: a systematic review
Miechowski W et al. — Otolaryngol Pol (2026-02) · Systematic Review
Systematic review of steroid-eluting sinus stents for CRS.
PubMed · DOI · PMID 42138052 -
Long-Term Risk of Revision Surgery Following Balloon Sinuplasty Versus Endoscopic Sinus Surgery
Parikh MJ et al. — Ann Otol Rhinol Laryngol (2025-11) · Real-world cohort
TriNetX 5-year retrospective comparison of revision risk and healthcare utilization after balloon sinuplasty vs ESS.
PubMed · DOI · PMID 41190449 -
Balloon sinuplasty: does a model simulator improve ENT trainee competence?
Pinto R et al. — Ann R Coll Surg Engl (2025-10) · Original
Model simulator improves ENT trainee competence in balloon sinuplasty.
PubMed · DOI · PMID 41117770 -
Readability and Understandability of Online Patient Materials on Balloon Sinuplasty
Bhalla SR et al. — OTO Open (2025-10) · Original
Assessment of readability/understandability of online balloon-sinuplasty patient materials.
PubMed · DOI · PMID 41179502 -
Efficacy of Balloon Sinuplasty over Conventional FESS
Suresh V et al. — Indian J Otolaryngol Head Neck Surg (2025-06) · Original
Comparative study of balloon sinuplasty vs conventional functional endoscopic sinus surgery.
PubMed · DOI · PMID 40727145 -
Evaluation of LYR-220 Mometasone Sinonasal Implant (BEACON)
Senior BA et al. — Int Forum Allergy Rhinol (2025-03) · RCT (Phase 2)
BEACON multicenter Phase 2 RCT of LYR-220, a long-acting 24-week mometasone sinonasal implant vs sham in post-ESS CRS.
PubMed · DOI · PMID 40099952
Devices / industry & non-PubMed sources
-
Medtronic NuVent EM Sinus Dilation System — FDA clearance — Medical Design & Outsourcing (2023+)
Electromagnetically navigated balloon sinus dilation integrated with the Fusion ENT navigation system.
Source -
ARS Position Statement: Criteria for Drug-Eluting Implants — American Rhinologic Society (2024)
Society guidance on appropriate use criteria for drug-eluting sinus implants (PROPEL, SINUVA).
Source
Sources indexed via PubMed (NCBI). Each entry links to its PubMed record and DOI.